These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 9667590

  • 1. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F, Polak T, Günther A, Kubuschok B, Janovskaja J, Bitsch A, Poser S, Rieckmann P.
    Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
    [Abstract] [Full Text] [Related]

  • 2. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F, Di Marco R, Patti F, Zaccone P, L'Episcopo MR, Reggio E, Xiang M, Nicoletti A, Reggio A.
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [Abstract] [Full Text] [Related]

  • 3. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V, Matusevicius D, Söderström M, Pirskanen R, Fredrikson S, Link H.
    Clin Neuropharmacol; 1998 Jun; 21(4):236-44. PubMed ID: 9704165
    [Abstract] [Full Text] [Related]

  • 4. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B.
    Rev Neurol; 1998 Jun; 29(10):893-9. PubMed ID: 10637835
    [Abstract] [Full Text] [Related]

  • 5. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.
    Sarchielli P, Critelli A, Greco L, Sokola E, Floridi A, Gallai V.
    Cytokine; 2001 Jun 07; 14(5):294-8. PubMed ID: 11444910
    [Abstract] [Full Text] [Related]

  • 6. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb 07; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 7. Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.
    Dressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber F.
    Acta Neurol Scand; 2006 Dec 07; 114(6):368-73. PubMed ID: 17083335
    [Abstract] [Full Text] [Related]

  • 8. IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines.
    Sega S, Wraber B, Mesec A, Horvat A, Ihan A.
    Clin Neurol Neurosurg; 2004 Jun 07; 106(3):255-8. PubMed ID: 15177779
    [Abstract] [Full Text] [Related]

  • 9. Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
    Jensen J, Krakauer M, Sellebjerg F.
    Cytokine; 2005 Jan 07; 29(1):24-30. PubMed ID: 15579375
    [Abstract] [Full Text] [Related]

  • 10. CD45RA+ ICAM-3+ lymphocytes in interferon-beta1b-treated and -untreated patients with relapsing-remitting multiple sclerosis.
    Chatzimanolis N, Kraus J, Bauer R, Engelhardt B, Bregenzer T, Kuehne BS, Tofighi J, Laske C, Stolz E, Blaes F, Voigt K, Traupe H, Kaps M, Oschmann P.
    Acta Neurol Scand; 2004 Dec 07; 110(6):377-85. PubMed ID: 15527450
    [Abstract] [Full Text] [Related]

  • 11. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 07; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 12. Effects of interferon-beta on the cytokine production of astrocytes.
    Okada K, Kuroda E, Yoshida Y, Yamashita U, Suzumura A, Tsuji S.
    J Neuroimmunol; 2005 Feb 07; 159(1-2):48-54. PubMed ID: 15652402
    [Abstract] [Full Text] [Related]

  • 13. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F, Weber F, Huber S, Sotgiu S, Czlonkowska A, Holler E, Albert E, Weiss EH, Wekerle H, Hohlfeld R.
    Ann Neurol; 1995 Nov 07; 38(5):723-30. PubMed ID: 7486863
    [Abstract] [Full Text] [Related]

  • 14. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F.
    Mult Scler; 2008 Jun 07; 14(5):622-30. PubMed ID: 18424480
    [Abstract] [Full Text] [Related]

  • 15. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
    Yushchenko M, Mäder M, Elitok E, Bitsch A, Dressel A, Tumani H, Bogumil T, Kitze B, Poser S, Weber F.
    J Neurol; 2003 Oct 07; 250(10):1224-8. PubMed ID: 14586607
    [Abstract] [Full Text] [Related]

  • 16. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K, Reder AT.
    Mult Scler; 2007 May 07; 13(4):459-70. PubMed ID: 17463069
    [Abstract] [Full Text] [Related]

  • 17. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 18. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F, Raddatz D, Ho NA, Yeruva S, Dudas J, Ramadori G.
    Transl Res; 2007 Oct 15; 150(4):223-32. PubMed ID: 17900510
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms underlying the synergistic effect of Th1 cytokines on RANTES chemokine production by human glial cells.
    Li QQ, Bever CT.
    Int J Mol Med; 2001 Feb 15; 7(2):187-95. PubMed ID: 11172624
    [Abstract] [Full Text] [Related]

  • 20. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.
    Clin Immunol; 2008 Oct 15; 129(1):80-9. PubMed ID: 18653385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.